Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...

2-Year U.S. Treasury Note Continuous Contract $104.082 0.078 0.08% 5-Year U.S. Treasury Note Continuous Contract $109.234 0.141 0.13% 10-Year U.S. Treasury Note Continuous Contract $112.281 0.125 ...